These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets. Kwon HR; Green P; Curry SH Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909 [TBL] [Abstract][Full Text] [Related]
3. Incomplete and delayed bioavailability of sublingual nitroglycerin. Noonan PK; Benet LZ Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat. Fung HL; Ogata H; Kamiya A; Maier GA J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996 [TBL] [Abstract][Full Text] [Related]
5. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration. Noonan PK; Benet LZ Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism. Wester RC; Noonan PK; Smeach S; Kosobud L J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893 [TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations. Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809 [TBL] [Abstract][Full Text] [Related]
9. Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure. Kamiya A; Ogata H; Fung HL J Pharm Sci; 1982 Jun; 71(6):621-4. PubMed ID: 6808113 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. Chien YW Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites. Jensen KM; Dahl JB Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of two nitroglycerin dosage forms: a metered spray and a soft gelatin capsule. Erb R; Stoltman W J Pharmacokinet Biopharm; 1983 Dec; 11(6):611-21. PubMed ID: 6431075 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)]. Maier-Lenz H; Ringwelski L; Windorfer A Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nitroglycerin and its dinitrate metabolites over a thirtyfold range of oral doses. Nakashima E; Rigod JF; Lin ET; Benet LZ Clin Pharmacol Ther; 1990 May; 47(5):592-8. PubMed ID: 2111749 [TBL] [Abstract][Full Text] [Related]
17. Nitroglycerin stability: effects on bioavailability, assay and biological distribution. Sokoloski TD; Wu CC J Clin Hosp Pharm; 1981 Dec; 6(4):227-32. PubMed ID: 6802877 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs. Lee FW; Salmonson T; Metzler CH; Benet LZ J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621 [TBL] [Abstract][Full Text] [Related]
19. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing. Yu DK; Williams RL; Benet LZ; Lin ET; Giesing DH Biopharm Drug Dispos; 1988; 9(6):557-65. PubMed ID: 3147725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]